IGX Logo Medium Size.jpg
IntelGenx Engages Focus Communications for Investor Relations Program
30 nov. 2018 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce the engagement of Focus Communications...
IGX Logo Medium Size.jpg
IntelGenx Begins Montelukast VersaFilm™ Dosing in Patients with Mild to Moderate Alzheimer’s Disease in Phase 2a Study
27 nov. 2018 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that patient dosing has commenced in the Phase 2a...
IGX Logo Medium Size.jpg
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®
20 nov. 2018 08h00 HE | IntelGenx Technologies Corp.
- PDUFA Goal Date of April 1, 2019 - SAINT LAURENT, Quebec, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that its...
IGX Logo Medium Size.jpg
IntelGenx Closes Private Placement Financing
13 nov. 2018 16h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic...
IGX Logo Medium Size.jpg
IntelGenx Reports Third Quarter 2018 Financial Results
08 nov. 2018 16h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
IGX Logo Medium Size.jpg
IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm™ Products
07 nov. 2018 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
IGX Logo Medium Size.jpg
IntelGenx Announces Exercise of Over-Allotment Option
26 oct. 2018 16h02 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces that in connection with its previously...
IGX Logo Medium Size.jpg
IntelGenx Completes US$12 Million Equity Offering
22 oct. 2018 18h53 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 22, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed its...
IGX Logo Medium Size.jpg
IntelGenx Announces Proposed Equity Offering
17 oct. 2018 16h25 HE | IntelGenx Technologies Corp.
SAINT LAURENT,, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that it intends to distribute  units (the...
IGX Logo Medium Size.jpg
IntelGenx Receives Over $1.6 Million from Exercise of Warrants
17 oct. 2018 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that, since September 15, 2018,...